This public procurement record has 2 releases in its history.

Award

11 Feb 2021 at 00:00

Tender

08 Oct 2020 at 01:00

Summary of the contracting process

The Common Services Agency (NHS National Services Scotland) is currently undertaking a procurement process for a contract titled "Cytokine Modulators" in the healthcare industry. This procurement is at the Award stage, with key components including a total contract value of £146,393,864, covering a period of 24 months with the possibility of a further 24-month extension. The contract involves the delivery of cytokine modulators in various specified categories (lots) to entities established under the National Health Service (Scotland) Act 1978 across various locations in the UK. The decision for awarding this contract was made on 11th January 2021, with electronic submissions being mandatory for this open procurement procedure.

This tender presents substantial opportunities for businesses, particularly those involved in the pharmaceutical sector, such as suppliers of injectable medications and healthcare products. Given the nature of the goods involved, companies with expertise in manufacturing or supplying cytokine modulators, particularly those who can demonstrate compliance with stringent regulatory requirements, would be well-positioned to compete. With several lots available, both large and small enterprises can potentially participate, especially those equipped to meet the various technical and quality control criteria specified by NHS Scotland.

How relevant is this notice?

Notice Title

Cytokine Modulators

Notice Description

Supply of Cytokine Modulators to NHS Scotland which is used to treat licensed indications. Etanercept Infliximab Adalimumab Methotrexate The Goods have been split into eight (8) categories, each of which are identified as a "Lot". Full details of each Lot are contained in section II.2 of this notice.

Lot Information

Adalimumab

Supply of Adalimumab to NHS Scotland. The Authority has awarded this Lot as a unranked multi-supplier framework per line to five (5) Framework Participants.

Renewal: This framework includes the option(s) to extend for up to a total period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Etanercept

Supply of Etanercept to NHS Scotland. The Authority has awarded this Lot as a unranked multi-supplier framework per line to three (3) Framework Participants.

Renewal: This framework includes the option(s) to extend for up to a total period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Infliximab IV

Supply of Infliximab IV to NHS Scotland. The Authority has awarded this Lot as a unranked multi-supplier framework per line to five (5) Framework Participants.

Renewal: This framework includes the option(s) to extend for up to a total period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Methotrexate (50 mg per 1 ml concentration ) pre-filled self injection device

Supply of Methotrexate (50 mg per 1 ml concentration ) pre-filled self injection device to NHS Scotland. The Authority has awarded this Lot as a unranked multi-supplier framework per line to two (2) Framework Participants.

Renewal: This framework includes the option(s) to extend for up to a total period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Methotrexate (50 mg per 1 ml concentration ) pre-filled syringes

Supply of Methotrexate (50 mg per 1 ml concentration ) pre-filled syringes to NHS Scotland. The Authority has awarded this Lot as a unranked multi-supplier framework per line to one (1) Framework Participant.

Renewal: This framework includes the option(s) to extend for up to a total period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Methotrexate (25 mg per 1 ml concentration ) pre-filled self injection device

Supply of Methotrexate (25mg per 1 ml concentration ) pre-filled self injection device to NHS Scotland. The Authority has awarded this Lot as a unranked multi-supplier framework per line to one (1) Framework Participant.

Renewal: This framework includes the option(s) to extend for up to a total period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Methotrexate (25mg per 1 ml concentration ) pre-filled syringes

Supply of Methotrexate (25 mg per 1 ml concentration) pre-filled syringes to NHS Scotland. The Authority has awarded this Lot as a unranked multi-supplier framework per line to one (1) Framework Participant.

Renewal: This framework includes the option(s) to extend for up to a total period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Infliximab Subcutaneous

Supply of Infliximab Subcutaneous to NHS Scotland. The Authority has awarded this Lot as a single supplier framework per line to one (1) Framework Participant.

Renewal: This framework includes the option(s) to extend for up to a total period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Publication & Lifecycle

Open Contracting ID
ocds-r6ebe6-0000631656
Publication Source
Public Contracts Scotland
Latest Notice
https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=FEB406448
Current Stage
Award
All Stages
Tender, Award

Procurement Classification

Notice Type
OJEU - F3 - Contract Award Notice
Procurement Type
Framework
Procurement Category
Goods
Procurement Method
Open
Procurement Method Details
Open procedure
Tender Suitability
Not specified
Awardee Scale
Large, SME

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products


CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
£146,393,864 £100M-£1B
Lots Value
£146,393,863 £100M-£1B
Awards Value
Not specified
Contracts Value
£116,643,215 £100M-£1B

Notice Dates

Publication Date
11 Feb 20215 years ago
Submission Deadline
12 Nov 2020Expired
Future Notice Date
Not specified
Award Date
11 Jan 20215 years ago
Contract Period
Not specified - Not specified
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Complete
Awards Status
Not Specified
Contracts Status
Active

Contracting Authority (Buyer)

Main Buyer
The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
EDINBURGH
Postcode
EH12 9EB
Postcode Area
Edinburgh
Country
Scotland

Major Region (ITL 1)
TLM Scotland
Basic Region (ITL 2)
TLM1 East Central Scotland
Small Region (ITL 3)
TLM13 City of Edinburgh
Delivery Location
TLM Scotland

Local Authority
City of Edinburgh
Electoral Ward
Drum Brae/Gyle
Westminster Constituency
Edinburgh South West

Supplier Information

Number of Suppliers
12
Supplier Names

AbbVie Ltd

Accord UK Ltd

Accord-UK Ltd

Biogen Idec Ltd.

Celltrion Healthcare United Kingdom Limited

Fresenius Kabi Limited

Merck Sharp & Dohme

Nordic Pharma Ltd

Pfizer Ltd

Sandoz Ltd

amgen ltd

medac Pharma LLP

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...